Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

C5a Receptor Expression in Circulating Myeloid Cells in ARDS Secondary to COVID-19

NCT04369820 is registered in ClinicalTrials.gov with Assistance Publique Hopitaux De Marseille as lead sponsor.

NCT NCT04369820
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04369820 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
C5a Receptor Expression in Circulating Myeloid Cells in ARDS Secondary to COVID-19
Lead sponsor
Assistance Publique Hopitaux De Marseille
Phase
Not applicable
Overall status
Completed
Start date
March 31, 2020
Completion date
August 9, 2023
Enrollment
61 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19